Navigation Links
MET protein levels show promise as biomarker for aggressive colon cancer
Date:6/4/2013

HOUSTON - MET protein levels correlate strongly with epithelial-mesenchymal transition (EMT) phenotype, a treatment-resistant type of colorectal cancer and may be used as a surrogate biomarker, according to new research from The University of Texas MD Anderson Cancer Center.

The study results, which compared MET protein expression with protein/gene expression of EMT markers and evaluated impact on survival, were released today at the annual meeting of the American Society of Clinical Oncology.

"When the epithelial cells that line the colon become cancerous, some of them develop special features to allow migration, causing the cancer to be more aggressive," said Kanwal Pratap Singh Raghav, M.D., fellow in MD Anderson's Division of Cancer Medicine. "Although EMT is a dominant molecular subtype, a biomarker suitable for clinical use has not been found. This research gives us an important step toward learning more about treating this colorectal cancer subtype."

In a bigger picture view, the study provides another piece of the puzzle of personalized cancer diagnosis and treatment.

"While we know there are many of types of colorectal cancer, we're not as advanced as we'd like to be in our understanding of them," said Scott Kopetz, M.D., Ph.D., associate professor in MD Anderson's Department of Gastrointestinal Medical Oncology and senior author of the study. "One of the larger goals of our research is to classify simple biomarkers that can be used by doctors in the community to identify subtypes. We want to condense sophisticated gene signatures down to single markers and simple tests that can be used to guide therapy."

The data were tested with:

  • Mann-Whitney U-test and Spearman rank correlation to determine association between MET protein expression and protein/gene expression of EMT markers and EMT gene signature scores
  • Regression tree method and Kaplan-Meier estimates to assess over
    '/>"/>

Contact: Laura Sussman
sussman@mdanderson.org
832-264-8893
University of Texas M. D. Anderson Cancer Center
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Researchers gain insight into key protein linked to cancers, neurodegenerative disorders
2. Advancement in Biologic Protein Expression Webinar Hosted by Selexis SA
3. German and Israeli scientists gain new insights into protein disposal
4. Proteins in migration
5. Preclinical tests shows agent stops slippery proteins from binding, causing Ewing sarcoma
6. Study IDs key protein for cell death
7. Tumor-activated protein promotes cancer spread
8. Cancer drug prevents build-up of toxic brain protein
9. Amplification of a Stat5 gene produces excess oncogenic protein that drives prostate cancer spread
10. Can High-Protein, Low-Carb Diet Boost Fertility Treatment?
11. Assembly of a protein degradation machine could lead to treatments in cancer, neurological diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/30/2015)... Orange, CA (PRWEB) , ... August 30, 2015 , ... ... just announced a back to school special. The company is currently offering lice head ... $25. In addition, the company is offering a 10% discount on their lice treatment ...
(Date:8/30/2015)... Boca Raton, Fl (PRWEB) , ... August 30, ... ... that Brian Spector has joined the company as the new Global Communications Director ... broadcasting and public relations experience having spent the last 16 years doing on-air ...
(Date:8/30/2015)... (PRWEB) , ... August 30, 2015 , ... Certified Nutrition ... Nutritional Products International and InHealth media is a global sales and communications firm ... are extremely pleased to continue our business relationship with Mr. Reid Eckert, as his ...
(Date:8/30/2015)... ... August 30, 2015 , ... Nutritional Products International ... assistant to Executive Assistant to CEO Mitch Gould for Nutritional Products International. ... your goals. Kathleen graduated from Florida State University with a Bachelor of ...
(Date:8/29/2015)... ... August 30, 2015 , ... Rio Salado College ... as the college’s Vice President of Strategic Initiatives and Information Services. O’Shea, who has ... the college expand its reach and impact through innovative technologies and strategies. , “I ...
Breaking Medicine News(10 mins):Health News:Lizzie’s Lice Pickers Announces Back to School Head Check Special and Discounted Lice Treatment Products 2Health News:InHealth Media Appoints New Global Communications Director 2Health News:Nutrition Guru Continues Relationship With Renowned Health and Wellness Company 2Health News:NPI Appoints New Executive Assistant To CEO 2Health News:Rio Salado College Appoints New Vice President of Strategic Initiatives and Information Services 2
... supports the U.S. Senate in its introduction of the ... Radiation Therapy Act of 2010 (CARE Act), S. 3737. ... Sen. Mike Enzi [R-WY], aims to ensure that minimum ... set at the state level. The bill,s co-sponsors include ...
... Vitamin D may be an effective therapy to treat and ... severe complications for patients with cystic fibrosis and asthma, according ... University of Pittsburgh School of Medicine and Louisiana State University ... Kolls, M.D., Ph.D., a lung disease researcher at Children,s Hospital ...
... Gordon HealthDay Reporter , WEDNESDAY, Aug. 25 (HealthDay ... illnesses in America may share a connection, with new research ... your risk of developing the brain plaques associated with Alzheimer,s ... study found that people with the highest levels of fasting ...
... novel mechanism used by adenovirus to sidestep the cell,s suicide ... suppressor genes are silenced in tumor cells and pave the ... researchers at the Salk Institute for Biological Studies in the ... a cell is under stress, the tumor suppressor p53 springs ...
... (NYSE Amex:CUR) announced that it has filed an Investigational ... and Drug Administration (FDA) to begin a Phase I ... its spinal cord stem cells. This multicenter Phase I ... or chronic, spinal cord injury patients, with an American ...
... , WEDNESDAY, Aug. 25 (HealthDay News) -- U.S. scientists ... judge to halt any expansion of stem cell research ... blindsided the scientific community, effectively takes embryonic stem cell ... then-President George W. Bush ordered that federal monies could ...
Cached Medicine News:Health News:SNM applauds US Senate's introduction of CARE Act 2Health News:Vitamin D may treat and prevent allergic reaction to mold in cystic fibrosis patients 2Health News:Link Between Diabetes, Alzheimer's Disease Strengthened 2Health News:Link Between Diabetes, Alzheimer's Disease Strengthened 3Health News:Link Between Diabetes, Alzheimer's Disease Strengthened 4Health News:Use the common cold virus to target and disrupt cancer cells? 2Health News:Use the common cold virus to target and disrupt cancer cells? 3Health News:Neuralstem files FDA application for first chronic spinal cord injury stem cell trial 2Health News:Neuralstem files FDA application for first chronic spinal cord injury stem cell trial 3Health News:Obama to Appeal Stem Cell Ruling 2Health News:Obama to Appeal Stem Cell Ruling 3
(Date:8/30/2015)... LONDRES, August 30, 2015 ... de l cuidado al paciente ... trayecto   Royal Philips  (NYSE: ... de IntelliSpace Cardiovascular , un sistema web de ... para acceder, analizar y compartir imágenes cardiovasculares e información ...
(Date:8/28/2015)... Fla. , Aug. 28, 2015  With the ... reaching deadlier heights, Jacksonville -based ... Philip Hemphill is helping to explain why fentanyl ... is approximately 40 to 50 times more potent than ... recreational users as heroin, the risk of death skyrockets. ...
(Date:8/28/2015)... 28, 2015  CytomX Therapeutics, Inc., a biopharmaceutical company ... announced the filing of a registration statement on Form ... relating to a proposed initial public offering of its ... and the price range for the offering have not ... stock under the symbol "CTMX" on the NASDAQ Global ...
Breaking Medicine Technology:Philips presenta IntelliSpace Cardiovascular en el Congreso ESC 2015 2Philips presenta IntelliSpace Cardiovascular en el Congreso ESC 2015 3Lakeview Health's Dr. Philip Hemphill Explains Why Heroin Addicts Are Now Dying of Fentanyl Overdoses 2CytomX Files Registration Statement for Proposed Initial Public Offering 2
... Pevion Biotech AG today announced ... therapeutic Candida vaccine PEV7, demonstrating the generation of specific ... Furthermore, the results again confirm the capability of Pevion,s ... long-lasting immunity in humans against otherwise weak antigens ...
... Mass. and MIAMI, Jan. 16, 2012 Boston Scientific ... endpoint data from its ORION trial, demonstrating excellent outcomes ... patients with iliac artery disease, a form of peripheral ... insufficient blood flow.  Results were presented today by Daniel ...
Cached Medicine Technology:Pevion's Therapeutic Candida Vaccine Generates Functional B Cell Memory in all Vaccinees 2Pevion's Therapeutic Candida Vaccine Generates Functional B Cell Memory in all Vaccinees 3Boston Scientific Epic™ Stent Demonstrates Positive Clinical Outcomes in Orion Trial 2Boston Scientific Epic™ Stent Demonstrates Positive Clinical Outcomes in Orion Trial 3Boston Scientific Epic™ Stent Demonstrates Positive Clinical Outcomes in Orion Trial 4Boston Scientific Epic™ Stent Demonstrates Positive Clinical Outcomes in Orion Trial 5
... device allows for quick and ... ophthalmic surgical procedures. The "Quick ... through which a suture may ... during the loading procedure. The ...
Titanium. Small "H" shaped push-pull tip. Shaft angled 45 degrees, 9 mm from tip. Round knurled handle with dull finish. Overall length: 4.8 inches. Most popular size or model....
Left angled 5 mm blunt hook. Overall length: 9.9 inches....
This suture adjuster facilitates post operative suture adjustment of running sutures while decreasing the possibility of suture damage or breakage....
Medicine Products: